newsfilter
← Latest News
GlobeNewswire·

Maze Therapeutics Announces $150 Million Registered Offering

SOUTH SAN FRANCISCO, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (NASDAQ:MAZE) today announced the pricing of its underwritten registered offering of 5,540,000 shares of its common stock at a